Benzinga | May 6, 2021 04:32PM EDT

Harpoon Therapeutics Q1 EPS $(1.95) Down From $(0.51) YoY, Sales $9.01M Up From $3.30M YoY

Harpoon Therapeutics (NASDAQ:HARP) reported quarterly losses of $(1.95) per share. This is a 282.35 percent decrease over losses of $(0.51) per share from the same period last year. The company reported $9.01 million in sales this quarter. This is a 173.19 percent increase over sales of $3.30 million the same period last year.